hesperidin has been researched along with hesperidin methylchalcone in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (20.00) | 18.7374 |
| 1990's | 2 (6.67) | 18.2507 |
| 2000's | 2 (6.67) | 29.6817 |
| 2010's | 13 (43.33) | 24.3611 |
| 2020's | 7 (23.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnaud, B; Chanal, JL; Cousse, H; Marignan, R; Sicart, MT | 1 |
| Bouskela, E; Cyrino, FZ; Marcelon, G | 1 |
| Berna, N; Bouaziz, N; Eliaers, F; Janssens, D; Michiels, C; Panconi, E; Remacle, J | 1 |
| CHENOWETH, MB; DONTAS, AS | 1 |
| JOHNE, HO; MATIS, P; SCHEELE, J; WIEGMANN, J | 1 |
| GAY, A; MONTALE, P | 1 |
| Aguilar Peralta, GR; Arévalo Gardoqui, J; Llamas Macías, FJ; Martínez Macías, CG; Mendoza Cisneros, SA; Navarro Ceja, VH | 1 |
| MANN, M; PECK, FB | 1 |
| Chang, KC; Jeong, JJ; Kang, SS; Kim, HJ; Kim, YS; Lee, SH; Nizamutdinova, IT; Xu, GH | 1 |
| KIRTLEY, WR; PECK, FB | 1 |
| Avril, L; Enrici, E; Enriquez, E; Guex, JJ; Lis, C; Taïeb, C | 1 |
| Allaert, FA; Cazaubon, M; Clavel, T; Escourrou, P; Hugue, C; Renaudin, JM | 1 |
| Bracke, ME; Heugebaert, TS; Roman, BI; Stevens, CV | 1 |
| Borghi, SM; Casagrande, R; Guazelli, CF; Hohmann, MS; Manchope, MF; Pinho-Ribeiro, FA; Verri, WA; Zarpelon, AC | 1 |
| Andersen, KE | 1 |
| Baracat, MM; Casagrande, R; Caviglione, CV; Georgetti, SR; Martinez, RM; Pinho-Ribeiro, FA; Steffen, VS; Verri, WA; Vignoli, JA | 1 |
| Aleksiejew-Kleszczyński, T; Chudek, J; Hering, A; Iłżecki, M; Kobielski, A; Kobusiewicz, W; Mikosiński, J; Stec, J; Umiński, J; Urbanek, T; Wojtak, A; Zubilewicz, T | 1 |
| Breccia, JD; Halada, P; Kotik, M; Křen, V; Mazzaferro, LS; Neher, BD; Oyhenart, J | 1 |
| Allaert, FA | 1 |
| Baracat, MM; Casagrande, R; Caviglione, CV; Georgetti, SR; Martinez, RM; Pala, D; Pinho-Ribeiro, FA; Steffen, VS; Verri, WA | 1 |
| Allaert, FA; Bouskela, E; Jawien, A; Nicolaïdes, AN | 1 |
| Bouskela, E; Jawien, A; Kakkos, SK; Nicolaides, AN | 1 |
| Alves-Filho, JC; Amaral, FA; Borghi, SM; Casagrande, R; Cunha, FQ; Cunha, TM; Fattori, V; Pinho-Ribeiro, FA; Ruiz-Miyazawa, KW; Staurengo-Ferrari, L; Teixeira, MM; Verri, WA | 1 |
| Artero, NA; Badaro-Garcia, S; Casagrande, R; de Freitas, A; Fattori, V; Ferraz, CR; Manchope, MF; Rasquel-Oliveira, FS; Saraiva-Santos, T; Staurengo-Ferrari, L; Verri, WA; Zaninelli, TH | 1 |
| Baracat, MM; Borghi, SM; Casagrande, R; Fattori, V; Ferraz, CR; Guazelli, CFS; Verri, WA | 1 |
| Monjotin, N; Tenca, G | 1 |
| Borghi, SM; Casagrande, R; Verri, WA | 1 |
| Li, X; Li, Y; Liang, H; Liu, K; Liu, S; Ma, Z; Wang, Y; Wu, C; Xiao, Y; Yu, J; Zhou, L | 1 |
| Abirami, G; Alexpandi, R; Cai, Y; Durgadevi, R; Kumar, P; Ravi, AV; Roshni, PS | 1 |
| Aguiar, AF; Bertozzi, MM; Borghi, SM; da Silva-Araújo, AK; Heintz, OK; Júnior, EO; Luque, MZ; Saraiva-Santos, T; Souza, NA; Verri, WA; Zaninelli, TH | 1 |
4 review(s) available for hesperidin and hesperidin methylchalcone
| Article | Year |
|---|---|
Assessment of the antineoplastic potential of chalcones in animal models.
Topics: Animals; Antineoplastic Agents; Chalcones; Disease Models, Animal; Hesperidin; Humans; Structure-Activity Relationship | 2013 |
Combination of Ruscus aculeatus extract, hesperidin methyl chalcone and ascorbic acid: a comprehensive review of their pharmacological and clinical effects and of the pathophysiology of chronic venous disease.
Topics: Ascorbic Acid; Chalcones; Chronic Disease; Drug Therapy, Combination; Hesperidin; Humans; Phytotherapy; Plant Extracts; Randomized Controlled Trials as Topic; Ruscus; Vascular Diseases; Veins | 2016 |
The place of Ruscus extract, hesperidin methyl chalcone, and vitamin C in the management of chronic venous disease.
Topics: Ascorbic Acid; Chalcones; Chronic Disease; Congresses as Topic; Drug Therapy, Combination; Hesperidin; Humans; London; Phytotherapy; Plant Extracts; Randomized Controlled Trials as Topic; Ruscus; Treatment Outcome; Vascular Diseases; Veins | 2017 |
New data on chronic venous disease: a new place for Cyclo 3® Fort.
Topics: Animals; Ascorbic Acid; Chalcones; Chronic Disease; Congresses as Topic; Drug Therapy, Combination; Hesperidin; Humans; Phytotherapy; Plant Extracts; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Ruscus; Venous Insufficiency | 2018 |
3 trial(s) available for hesperidin and hesperidin methylchalcone
| Article | Year |
|---|---|
Quality of life improvement in Latin American patients suffering from chronic venous disorder using a combination of Ruscus aculeatus and hesperidin methyl-chalcone and ascorbic acid (quality study).
Topics: Adult; Aged; Argentina; Ascorbic Acid; Cardiovascular Agents; Chalcones; Chronic Disease; Drug Combinations; Female; Hesperidin; Humans; Logistic Models; Male; Mexico; Middle Aged; Odds Ratio; Plant Preparations; Prospective Studies; Quality of Life; Risk Assessment; Risk Factors; Ruscus; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venous Insufficiency | 2010 |
Correlation between improvement in functional signs and plethysmographic parameters during venoactive treatment (Cyclo 3 Fort).
Topics: Activities of Daily Living; Analysis of Variance; Ascorbic Acid; Cardiovascular Agents; Chalcones; Chi-Square Distribution; Drug Therapy, Combination; Female; France; Hesperidin; Humans; Plant Extracts; Plethysmography; Predictive Value of Tests; Recovery of Function; Ruscus; Treatment Outcome; Ultrasonography, Doppler; Venous Insufficiency | 2011 |
Evaluation of a preemptive intervention regimen with hesperidin methyl chalcone in delayed-onset muscle soreness in young adults: a randomized, double-blinded, and placebo-controlled trial study.
Topics: Chalcones; Exercise; Hesperidin; Humans; Male; Muscle, Skeletal; Myalgia; Young Adult | 2023 |
23 other study(ies) available for hesperidin and hesperidin methylchalcone
| Article | Year |
|---|---|
Absorption and elimination of (14C) hesperidin methylchalcone in the rat.
Topics: Absorption; Administration, Oral; Animals; Biological Availability; Carbon Radioisotopes; Chalcone; Chalcones; Feces; Flavonoids; Hesperidin; Injections, Intravenous; Kinetics; Male; Propiophenones; Rats; Rats, Inbred Strains | 1981 |
Inhibitory effect of the Ruscus extract and of the flavonoid hesperidine methylchalcone on increased microvascular permeability induced by various agents in the hamster cheek pouch.
Topics: Animals; Bradykinin; Capillary Permeability; Chalcone; Chalcones; Cheek; Cricetinae; Dextrans; Fluorescein-5-isothiocyanate; Hesperidin; Histamine; Leukotriene B4; Male; Mesocricetus; Molecular Weight; Mouth Mucosa; Plant Extracts; Regional Blood Flow | 1993 |
Effect of Ruscus extract and hesperidin methylchalcone on hypoxia-induced activation of endothelial cells.
Topics: Adenosine Triphosphate; Cell Adhesion; Cell Hypoxia; Cells, Cultured; Chalcone; Chalcones; Endothelium, Vascular; Hesperidin; Humans; In Vitro Techniques; Neutrophils; Phospholipases A; Phospholipases A2; Plant Extracts; Umbilical Veins | 1999 |
The effect of hesperidin methyl chalcone on the nervous control of the nictitating membrane.
Topics: Animals; Chalcones; Eyelids; Flavones; Hesperidin; Humans; Nictitating Membrane | 1952 |
[Experimental and clinical studies on topical treatment of side effects in local penicillin-streptomycin therapy with hesperidin-methylchalcone, a substance with vitamin P effect].
Topics: Biomedical Research; Chalcones; Flavones; Hesperidin; Humans; Penicillins; Streptomycin; Vitamins | 1953 |
[Oral administration of combined toluidine blue, hesperidin methylchalcone and vitamin C in therapy of hemorrhagic diseases].
Topics: Administration, Oral; Aniline Compounds; Ascorbic Acid; Chalcones; Coloring Agents; Flavonoids; Hemophilia A; Hesperidin; Hypoprothrombinemias; Leukemia; Prothrombin; Purpura; Purpura, Thrombocytopenic; Tolonium Chloride; Vitamins | 1957 |
Clinical and capillaroscopic evaluation in the treatment of chronic venous insufficiency with Ruscus aculeatus, hesperidin methylchalcone and ascorbic acid in venous insufficiency treatment of ambulatory patients.
Topics: Adult; Aged; Aged, 80 and over; Antioxidants; Ascorbic Acid; Chalcones; Chronic Disease; Female; Hesperidin; Humans; Leg; Male; Microscopic Angioscopy; Middle Aged; Phytotherapy; Plant Extracts; Ruscus; Venous Insufficiency | 2007 |
Effect of hesperidin methyl chalcone, vitamin P, on diabetic retinopathy.
Topics: Chalcones; Diabetes Mellitus; Diabetic Retinopathy; Eye; Hesperidin; Humans; Vitamins | 1949 |
Hesperidin, hesperidin methyl chalone and phellopterin from Poncirus trifoliata (Rutaceae) differentially regulate the expression of adhesion molecules in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells.
Topics: Blotting, Western; Cell Adhesion; Cell Adhesion Molecules; Chalcones; Coumarins; Endothelial Cells; Fruit; Hesperidin; Humans; Monocytes; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Poncirus; Protein Kinase C; Signal Transduction; Tumor Necrosis Factor-alpha; U937 Cells; Umbilical Veins; Vascular Cell Adhesion Molecule-1 | 2008 |
Administration of massive doses of vitamin P hesperidin methyl chalcone.
Topics: Chalcones; Hesperidin; Humans; Vitamin A; Vitamin K; Vitamins | 1948 |
Protective effects of the flavonoid hesperidin methyl chalcone in inflammation and pain in mice: role of TRPV1, oxidative stress, cytokines and NF-κB.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chalcones; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Hesperidin; Inflammation; Male; Mice; Molecular Structure; NF-kappa B; Oxidative Stress; Pain; Structure-Activity Relationship; TRPV Cation Channels | 2015 |
Hesperidin methyl chalcone - a new cosmetic contact allergen.
Topics: Aged; Chalcones; Cosmetics; Dermatitis, Allergic Contact; Facial Dermatoses; Female; Hesperidin; Humans | 2015 |
Hesperidin methyl chalcone inhibits oxidative stress and inflammation in a mouse model of ultraviolet B irradiation-induced skin damage.
Topics: Animals; Antioxidants; Chalcones; Cytokines; Disease Models, Animal; Edema; Glutathione; Hesperidin; Inflammation; Lipid Peroxidation; Matrix Metalloproteinase 9; Membrane Glycoproteins; Mice; Mice, Hairless; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; RNA, Messenger; Skin; Superoxides; Ultraviolet Rays | 2015 |
Patients' satisfaction with therapy methods of advanced chronic venous disease.
Topics: Aged; Ascorbic Acid; Chalcones; Chronic Disease; Female; Hesperidin; Humans; Male; Middle Aged; Patient Satisfaction; Phytotherapy; Plant Extracts; Ruscus; Severity of Illness Index; Varicose Ulcer; Wound Healing | 2016 |
Bacteria as source of diglycosidase activity: Actinoplanes missouriensis produces 6-O-α-L-rhamnosyl-β-D-glucosidase active on flavonoids.
Topics: Bacterial Proteins; beta-Glucosidase; Chalcones; Cloning, Molecular; Disaccharides; Escherichia coli; Flavonoids; Gene Expression; Glycosides; Hesperidin; Hydrolysis; Micromonosporaceae; Phylogeny; Recombinant Proteins; Rhamnose; Substrate Specificity | 2016 |
Topical formulation containing hesperidin methyl chalcone inhibits skin oxidative stress and inflammation induced by ultraviolet B irradiation.
Topics: Administration, Topical; Animals; Chalcones; Cytokines; Heme Oxygenase-1; Hesperidin; Inflammation; Membrane Glycoproteins; Mice; Mice, Hairless; NADPH Oxidase 2; NADPH Oxidases; NF-E2-Related Factor 2; Oxidative Stress; RNA, Messenger; Skin; Superoxides; Ultraviolet Rays | 2016 |
Hesperidin Methylchalcone Suppresses Experimental Gout Arthritis in Mice by Inhibiting NF-κB Activation.
Topics: Animals; Arthritis, Gouty; Chalcones; Hesperidin; Humans; Interleukin-1beta; Macrophages; Male; Mice; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Signal Transduction; Tumor Necrosis Factor-alpha | 2018 |
Hesperidin methyl chalcone interacts with NFκB Ser276 and inhibits zymosan-induced joint pain and inflammation, and RAW 264.7 macrophage activation.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antioxidants; Arthralgia; Arthritis, Experimental; Cell Line; Chalcones; Cytokines; Disease Models, Animal; Edema; Hesperidin; Inflammation; Macrophage Activation; Macrophages; Mice; Molecular Docking Simulation; NF-kappa B; Oxidative Stress; RAW 264.7 Cells; Signal Transduction; Zymosan | 2020 |
Antioxidant and anti-inflammatory effects of hesperidin methyl chalcone in experimental ulcerative colitis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Chalcones; Colitis, Ulcerative; Colon; Cytokines; Disease Models, Animal; Edema; Hesperidin; Male; Mice; Neutrophil Infiltration; NF-kappa B; Oxidative Stress | 2021 |
Lymphotonic activity of Ruscus extract, hesperidin methyl chalcone and vitamin C in human lymphatic smooth muscle cells.
Topics: Ascorbic Acid; Calcium; Calcium Signaling; Cells, Cultured; Chalcones; Diosmin; Dose-Response Relationship, Drug; Drug Combinations; Gene Expression Regulation; Hesperidin; Humans; Lymphatic Vessels; Male; Middle Aged; Muscle Contraction; Myocytes, Smooth Muscle; Plant Extracts; Ruscus; Time Factors | 2022 |
Hesperidin Methyl Chalcone: An Emerging Compound for the Treatment of Inflammation and Pain.
Topics: Chalcone; Chalcones; Hesperidin; Humans; Inflammation; Pain | 2023 |
Hesperidin methyl chalcone ameliorates lipid metabolic disorders by activating lipase activity and increasing energy metabolism.
Topics: Animals; Chalcones; Energy Metabolism; Flavonoids; Hesperidin; Lipase; Lipid Metabolism Disorders; Lipids; Mice; Obesity | 2023 |
Hesperidin methyl chalcone, a citrus flavonoid, inhibits Aeromonas hydrophila infection mediated by quorum sensing.
Topics: Aeromonas hydrophila; Animals; Bacterial Proteins; Biofilms; Chalcones; Flavonoids; Hesperidin; Humans; Virulence Factors; Zebrafish | 2023 |